InfuSystem Holdings, Inc. (NYSE:INFU) Forecasted to Earn Q3 2024 Earnings of $0.08 Per Share

InfuSystem Holdings, Inc. (NYSE:INFU) – B. Riley issued their Q3 2024 EPS estimates for InfuSystem in a note issued to investors on Wednesday, September 25th. B. Riley analyst K. Bauser anticipates that the company will post earnings per share of $0.08 for the quarter. B. Riley currently has a “Strong-Buy” rating on the stock. B. Riley also issued estimates for InfuSystem’s Q4 2024 earnings at $0.10 EPS, FY2024 earnings at $0.17 EPS, Q1 2025 earnings at $0.09 EPS, Q2 2025 earnings at $0.09 EPS, Q3 2025 earnings at $0.09 EPS, Q4 2025 earnings at $0.10 EPS, FY2025 earnings at $0.37 EPS and FY2026 earnings at $0.49 EPS.

InfuSystem (NYSE:INFU) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The firm had revenue of $33.70 million for the quarter. InfuSystem had a net margin of 0.28% and a return on equity of 0.70%.

Separately, StockNews.com lowered shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a research note on Saturday.

InfuSystem Stock Performance

Shares of NYSE:INFU opened at $6.75 on Monday. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.07 and a quick ratio of 1.64. The firm has a market capitalization of $143.74 million, a P/E ratio of -675,000.00 and a beta of 1.46. InfuSystem has a 12-month low of $5.74 and a 12-month high of $10.99.

Institutional Trading of InfuSystem

Several institutional investors have recently added to or reduced their stakes in the business. Kings Path Partners LLC acquired a new position in shares of InfuSystem during the second quarter valued at $514,000. First Eagle Investment Management LLC lifted its holdings in InfuSystem by 12.7% in the first quarter. First Eagle Investment Management LLC now owns 605,235 shares of the company’s stock worth $5,187,000 after purchasing an additional 68,021 shares during the period. Sequoia Financial Advisors LLC acquired a new stake in InfuSystem in the second quarter worth about $272,000. Squarepoint Ops LLC acquired a new stake in InfuSystem in the second quarter worth about $230,000. Finally, Ranger Investment Management L.P. lifted its holdings in InfuSystem by 4.7% in the fourth quarter. Ranger Investment Management L.P. now owns 689,842 shares of the company’s stock worth $7,271,000 after purchasing an additional 30,835 shares during the period. Institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.